ACF Investors — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders.
BiotechDeep TechHealthtechMedical DevicesMental HealthNorthern Ireland, GB
Dr. Jason McKeown(MD PhD, Founder)
Co-investorsClarendon Fund Managers Ltd.IQ CapitalStartXBeltrae PartnersBritish Business BankInnovation Ulster+2 more
Vantage Power develops electrification and connectivity technologies for commercial and defense vehicles, including hybrid-retrofit systems for city buses, liquid-cooled lithium-ion battery packs, and the VPVision data connectivity and analytics platform.
CleantechHardwareIoTMobility & Transportation
Alexander Schey(Co-founder)inToby Schulz(Co-founder)in
Co-investorsMartlet CapitalOrigin Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



.jpeg)



